Skip to main content
. 2021 May 6;9(5):463. doi: 10.3390/vaccines9050463

Figure 1.

Figure 1

surv.VLP-SS-MUC1 design and expression. (a) Diagram outlining the structure and position of survivin for surv.VLP. (b) Western blot for surv.VLP and control VLP. (c) Electron microscopy to confirm particle formation of surv.VLP and surv.VLP-SS-MUC1. (d) Conjugation strategy to attach MUC1 peptide on surv.VLP via bis-aryl-hydrazone linker.